Skip to main content
. 2021 Oct 1;15(6):247. doi: 10.3892/mco.2021.2409

Table III.

Yields of universal and age-restricted screening strategies.

Screening strategies Total, n dMMR tumor, n (%) bf-GTC, n (%) LS, n (%)
Universal screening 463 34 (7.3) 10 (2.2) 2 (0.4)
≤49 years 33 3 (9.1) 3 (9.1) 2 (6.1)
≤69 years 232 15 (6.5) 8 (3.4) 2 (0.9)
≥70 years 231 19 (8.2) 2 (0.9) 0 (0.0)

dMMR, deficient mismatch repair; bf-GTC, bona fide genetic testing candidate; LS, Lynch syndrome; GTC, genetic testing candidate.